Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.

Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing the HHS Vulnerability Disclosure link as well as Revision: v3.3.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page footer; this is a metadata/version update and does not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved a general government funding status notice from the page; the notice did not pertain to the study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check100 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topics and related MeSH terms from the page.SummaryDifference0.9%

- Check114 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. Overall, a minor update with no substantive changes to core content or pricing.SummaryDifference0.2%

Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.